Differences in integrin expression and signaling within human breast cancer cells
2011
Differences in Integrin Expression in Breast Cancer Cells
publication
Evidence: moderate
Author Information
Author(s): Taherian Aliakbar, Li Xinlei, Liu Yongqing, Haas Thomas A
Primary Institution: University of Saskatchewan
Hypothesis
Are there differences in the expression of integrins and their signaling within different breast cancer cell lines?
Conclusion
Breast cancer cells show significant variation in integrin expression and signaling, which may contribute to the heterogeneity of the disease.
Supporting Evidence
- All breast cancer cell lines expressed high levels of β1 and αv integrins.
- MDA-MB-435 cells uniquely expressed high levels of β3 and αvβ3 integrins.
- Integrin signaling varied significantly between metastatic and non-metastatic cell lines.
Takeaway
Different types of breast cancer cells use integrins differently, which can affect how they grow and spread.
Methodology
Integrin expression was measured using flow cytometry, and cell adhesion was assessed on various ECM proteins.
Limitations
The study primarily focuses on in vitro models and may not fully represent in vivo conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website